Technical Analysis for TEVA - Teva Pharmaceutical Industries

Grade Last Price % Change Price Change
grade F 6.745 -2.25% -0.16
TEVA closed up 2.37 percent on Friday, October 11, 2019, on 62 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical TEVA trend table...

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish -2.25%
Oversold Stochastic Weakness -2.25%
Oversold Stochastic Weakness 0.07%
NR7 Range Contraction 3.13%
Stochastic Reached Oversold Weakness 3.13%
Oversold Stochastic Weakness 3.13%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -3.37%
NR7 Range Contraction -3.37%
Spinning Top Other -3.23%
Oversold Stochastic Weakness -3.37%

Older signals for TEVA ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes pharmaceutical products worldwide. It offers generic pharmaceutical products; and basic chemical entities, as well as specialized product families, such as sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances. The company's principal branded pharmaceutical products comprise Copaxone for multiple sclerosis; Provigil and Nuvigil for the treatment of excessive sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work disorders; Azilect for the treatment of Parkinson's disease; Fentora and Actiq for the treatment of pain in opioid-tolerant adult patients with cancer; Amrix for muscle spasm in acute, painful, and musculoskeletal conditions; ProAir for the treatment of bronchial spasms; Qvar for long-term control of chronic bronchial asthma; and Qnasl Nasal Aerosol for seasonal nasal and year-round nasal allergy symptoms. The company also offers Treanda for the treatment of chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma; Tevagrastim/Ratiograstim that stimulate the production of white blood cells; Eporatio, which stimulates the production of red blood cells; Synribo for chronic myeloid leukemia; Plan B One-Step for emergency oral contraception; ParaGard, a non hormonal intrauterine contraceptive; hormone therapies for menopause/perimenopause; Enjuvia for vasomotor symptoms associated with menopause; and therapies for infertility and urinary incontinence. In addition, it produces active pharmaceutical ingredients in the areas of respiratory, cardiovascular, anti-cholesterol, central nervous system, dermatological, hormones, anti-inflammatory, oncology, immunosuppressants, and muscle relaxants. Further, the company distributes third party products. It has collaborative agreements with Lonza Group Ltd. and OncoGenex Pharmaceuticals, Inc. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.
Medicine Chemistry Cancer Pharmaceutical Pain Drugs Medication Pharmaceutical Products Multiple Sclerosis Lymphoma Parkinson's Disease Active Pharmaceutical Ingredients Asthma Leukemia Chronic Lymphocytic Leukemia Treatment Of Parkinson's Disease Obstructive Sleep Apnea Fentanyl Generic Pharmaceutical Products Muscle Spasm Party Products Treatment Of Chronic Lymphocytic Leukemia Urinary Incontinence Chronic Myeloid Leukemia Infertility Menopause Narcolepsy Teva Pharmaceutical Industries
Is TEVA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 23.97
52 Week Low 6.07
Average Volume 20,152,485
200-Day Moving Average 12.1696
50-Day Moving Average 7.148
20-Day Moving Average 7.086
10-Day Moving Average 6.834
Average True Range 0.3772
ADX 13.66
+DI 22.027
-DI 23.3995
Chandelier Exit (Long, 3 ATRs ) 7.318399999999999
Chandelier Exit (Short, 3 ATRs ) 7.5716
Upper Bollinger Band 7.9476
Lower Bollinger Band 6.2244
Percent B (%b) 0.39
BandWidth 24.318374
MACD Line -0.1774
MACD Signal Line -0.1553
MACD Histogram -0.0221
Fundamentals Value
Market Cap 7.01 Billion
Num Shares 1.02 Billion
EPS -6.11
Price-to-Earnings (P/E) Ratio -1.13
Price-to-Sales 0.60
Price-to-Book 0.57
PEG Ratio -0.47
Dividend 1.10
Dividend Yield 15.94%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.34
Resistance 3 (R3) 7.32 7.15 7.26
Resistance 2 (R2) 7.15 7.04 7.16 7.24
Resistance 1 (R1) 7.03 6.97 7.09 7.05 7.21
Pivot Point 6.86 6.86 6.90 6.87 6.86
Support 1 (S1) 6.74 6.75 6.80 6.76 6.59
Support 2 (S2) 6.57 6.68 6.58 6.56
Support 3 (S3) 6.45 6.57 6.54
Support 4 (S4) 6.47